TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 10, 2013, Pages 1744-1755

  Ucero, Alvaro C ^a   Benito Martin, Alberto ^a   Fuentes Calvo, Isabel ^b   Santamaria, Beatriz ^c   Blanco, Julia ^d   Lopez Novoa, Jose M ^b,f   Ruiz Ortega, Marta ^a,e   Egido, Jesus ^a,e,f   Burkly, Linda C ^g   Martinez Salgado, Carlos ^b,h   Ortiz, Alberto ^a,e,f  

^a 28400 Madrid   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f Section of Nephrology   (Spain)

^g BIOGEN   (United States)

^h HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Fn14; Kidney fibrosis; NF B; Proliferation; Ras; TWEAK

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR RELATED WEAK INDUCER OF APOPTOSIS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; INFLAMMATORY INFILTRATE; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; MOUSE; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

FN14; KIDNEY FIBROSIS; NFΚB; PROLIFERATION; RAS; TWEAK;

ANIMALS; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; FIBROSIS; KIDNEY; KIDNEY DISEASES; MICE; RAS PROTEINS; TUMOR NECROSIS FACTORS;

MURINAE; MUS;

EID: 84879595462     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.032     Document Type: Article

References (70)

1. Grande M.T., López-Novoa J.M. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol. 2009, 5:319-328.
2. Lee S.B., Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int. Suppl. 2010, S22-S26.
3. Ortiz A., Ucero A.C., Egido J. Unravelling fibrosis: two newcomers and an old foe. Nephrol. Dial. Transplant. 2010, 25:3492-3495.
4. Bechtel W., McGoohan S., Zeisberg E.M., Müller G.A., Kalbacher H., Salant D.J., Müller C.A., Kalluri R., Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 2010, 16:544-550.
5. Ortega A., Rámila D., Ardura J.A., Esteban V., Ruiz-Ortega M., Barat A., Gazapo R., Bosch R.J., Esbrit P. Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J. Am. Soc. Nephrol. 2006, 17:1594-1603.
6. Alexopoulos E., Seron D., Hartley R.B., Cameron J.S. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int. 1990, 37:100-109.
7. Müller G.A., Markovic-Lipkovski J., Frank J., Rodemann H.P. The role of interstitial cells in the progression of renal diseases. J. Am. Soc. Nephrol. 1992, 2:S198-S205.
8. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 1992, 20:1-17.
9. Strutz F., Müller G.A. On the progression of chronic renal disease. Nephron 1995, 69:371-379.
10. Ucero A.C., Gonalves S., Benito-Martin A., Santamaria B., Ramos A.M., Berzal S., Ruiz Ortega M., Egido J., Ortiz A. Obstructive renal injury: from fluid mechanics to molecular cell biology, open access. J. Urol. 2010, 2010(2):41-55.
11. Strutz F. Novel aspects of renal fibrogenesis. Nephrol. Dial. Transplant. 1995, 10:1526-1532.
12. Qi W., Chen X., Poronnik P., Pollock C.A. The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int. J. Biochem. Cell Biol. 2006, 38:1-5.
13. Sanchez-Niño M.D., Benito-Martin A., Gonçalves S., Sanz A.B., Ucero A.C., Izquierdo M.C., Ramos A.M., Berzal S., Selgas R., Ruiz-Ortega M., Egido J., Ortiz A. TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm. 2010, 2010.
14. Ortiz A., Lorz C., Gonzalez-Cuadrado S., Garcia del M.R., O'Valle F., Egido J. Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J. Am. Soc. Nephrol. 1997, 8:1845-1854.
15. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C., Garcia I., Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 1997, 272:32401-32410.
16. Sanz A.B., Sanchez-Nino M.D., Ortiz A. TWEAK, a multifunctional cytokine in kidney injury. Kidney Int. 2011, 80(7):708-718.
17. Burkly L.C., Michaelson J.S., Hahm K., Jakubowski A., Zheng T.S. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 2007, 40:1-16.
18. Winkles J.A. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat. Rev. Drug Discov. 2008, 7:411-425.
19. Hotta K., Sho M., Yamato I., Shimada K., Harada H., Akahori T., Nakamura S., Konishi N., Yagita H., Nonomura K., Nakajima Y. Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int. 2011, 79:179-188.
20. Justo P., Sanz A.B., Sanchez-Nino M.D., Winkles J.A., Lorz C., Egido J., Ortiz A. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 2006, 70:1750-1758.
21. Sanz A.B., Justo P., Sanchez-Niño M.D., Blanco-Colio L.M., Winkles J.A., Kreztler M., Jakubowski A., Blanco J., Egido J., Ruiz-Ortega M., Ortiz A. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J. Am. Soc. Nephrol. 2008, 19:695-703.
22. Sanz A.B., Sanchez-Nino M.D., Izquierdo M.C., Jakubowski A., Justo P., Blanco-Colio L.M., Ruiz-Ortega M., Egido J., Ortiz A. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J. Cell. Mol. Med. 2009, 13:3329-3342.
23. Dohi T., Borodovsky A., Wu P., Shearstone J.R., Kawashima R., Runkel L., Rajman L., Dong X., Scott M.L., Michaelson J.S., Jakubowski A., Burkly L.C. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Gastroenterology 2009, 136:912-923.
24. Li H., Mittal A., Paul P.K., Kumar M., Srivastava D.S., Tyagi S.C., Kumar A. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J. Biol. Chem. 2009, 284:4439-4450.
25. Munoz-Garcia B., Madrigal-Matute J., Moreno J.A., Martin-Ventura J.L., Lopez-Franco O., Sastre C., Ortega L., Burkly L.C., Egido J., Blanco-Colio L.M. TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells. Cardiovasc. Res. 2011, 89:225-233.
26. Tirnitz-Parker J.E., Viebahn C.S., Jakubowski A., Klopcic B.R., Olynyk J.K., Yeoh G.C., Knight B. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 2010, 52:291-302.
27. Liu Z.C., Zhou Q.L., Li X.Z., Yang J.H., Ao X., Veeraragoo P., Zuo X.X. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Cytokine 2011, 53:295-300.
28. Schwartz N., Rubinstein T., Burkly L.C., Collins C.E., Blanco I., Su L., Hojaili B., Mackay M., Aranow C., Stohl W., Rovin B.H., Michaelson J.S., Putterman C. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res. Ther. 2009, 11:R143.
29. Michaelson J.S., Wisniacki N., Burkly L.C., Putterman C. Role of TWEAK in lupus nephritis: a bench-to-bedside review. J. Autoimmun. 2012, 39:130-142.
30. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., Neilson E.G. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130:393-405.
31. Lorz C., Benito-Martín A., Boucherot A., Ucero A.C., Rastaldi M.P., Henger A., Armelloni S., Santamaría B., Berthier C.C., Kretzler M., Egido J., Ortiz A. The death ligand TRAIL in diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19:904-914.
32. Santamaría B., Benito-Martin A., Ucero A.C., Aroeira L.S., Reyero A., Vicent M.J., Orzáez M., Celdrán A., Esteban J., Selgas R., Ruíz-Ortega M., Cabrera M.L., Egido J., Pérez-Payá E., Ortiz A. A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury. PLoS One 2009, 4:e6634.
33. Justo P., Sanz A.B., Egido J., Ortiz A. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005, 54:2424-2429.
34. Ortiz A., Justo P., Sanz A., Melero R., Caramelo C., Guerrero M.F., Strutz F., Muller G., Barat A., Egido J. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir. Ther. 2005, 10:185-190.
35. Lorz C., Ortiz A., Justo P., González-Cuadrado S., Duque N., Gómez-Guerrero C., Egido J. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J. Am. Soc. Nephrol. 2000, 11:1266-1277.
36. Sanchez-Nino M.D., Sanz A.B., Ihalmo P., Lassila M., Holthofer H., Mezzano S., Aros C., Groop P.H., Saleem M.A., Mathieson P.W., Langham R., Kretzler M., Nair V., Lemley K.V., Nelson R.G., Mervaala E., Mattinzoli D., Rastaldi M.P., Ruiz-Ortega M., Martin-Ventura J.L., Egido J., Ortiz A. The MIF receptor CD74 in diabetic podocyte injury. J. Am. Soc. Nephrol. 2009, 20:353-362.
37. Sanz A.B., Sanchez-Nino M.D., Izquierdo M.C., Jakubowski A., Justo P., Blanco-Colio L.M., Ruiz-Ortega M., Selgas R., Egido J., Ortiz A. TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS One 2010, 5:e8955.
38. Campbell S., Burkly L.C., Gao H.X., Berman J.W., Su L., Browning B., Zheng T., Schiffer L., Michaelson J.S., Putterman C. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J. Immunol. 2006, 176:1889-1898.
39. Misaki T., Yamamoto T., Suzuki S., Fukasawa H., Togawa A., Ohashi N., Suzuki H., Fujigaki Y., Oda T., Uchida C., Kitagawa K., Hattori T., Kitagawa M., Hishida A. Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats. Am. J. Pathol. 2009, 175:74-83.
40. Diamond J., Kees-Folts D., Ricardo S., Pruznak A., Eufemio M. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am. J. Pathol. 1995, 146:1455-1466.
41. Morrissey J., Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am. J. Physiol. 1998, 274:F580-F586.
42. Vielhauer V., Anders H., Mack M., Cihak J., Strutz F., Stangassinger M., Luckow B., Gröne H., Schlöndorff D. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J. Am. Soc. Nephrol. 2001, 12:1173-1187.
43. Yoo K., Thornhill B., Forbes M., Coleman C., Marcinko E., Liaw L., Chevalier R. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int. 2006, 70:1735-1741.
44. Jain M., Jakubowski A., Cui L., Shi J., Su L., Bauer M., Guan J., Lim C.C., Naito Y., Thompson J.S., Sam F., Ambrose C., Parr M., Crowell T., Lincecum J.M., Wang M.Z., Hsu Y.M., Zheng T.S., Michaelson J.S., Liao R., Burkly L.C. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 2009, 119:2058-2068.
45. Rámila D., Ardura J., Esteban V., Ortega A., Ruiz-Ortega M., Bosch R., Esbrit P. Parathyroid hormone-related protein promotes inflammation in the kidney with an obstructed ureter. Kidney Int. 2008, 73:835-847.
46. Grande M.T., Fuentes-Calvo I., Arevalo M., Heredia F., Santos E., Martinez-Salgado C., Rodriguez-Puyol D., Nieto M.A., Lopez-Novoa J.M. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int. 2010, 77:509-518.
47. Minden A., Lin A., McMahon M., Lange-Carter C., Derijard B., Davis R.J., Johnson G.L., Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994, 266:1719-1723.
48. Rodriguez-Pena A.B., Grande M.T., Eleno N., Arevalo M., Guerrero C., Santos E., Lopez-Novoa J.M. Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int. 2008, 74:196-209.
49. Chen H.N., Wang D.J., Ren M.Y., Wang Q.L., Sui S.J. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-kB pathway. Mol. Biol. Rep. 2012, 39:8231-8241.
50. Li C., Hu Y., Sturm G., Wick G., Xu Q. Ras/Rac-dependent activation of p38 mitogen-activated protein kinases in smooth muscle cells stimulated by cyclic strain stress. Arterioscler. Thromb. Vasc. Biol. 2000, 20:E1-E9.
51. Li L., Fan D., Wang C., Wang J.Y., Cui X.B., Wu D., Zhou Y., Wu L.L. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK 1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc. Res. 2011, 91:80-89.
52. Leemans J.C., Butter L.M., Pulskens W.P., Teske G.J., Claessen N., van der Poll T., Florquin S. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009, 4:e5704.
53. Guo G., Morrissey J., McCracken R., Tolley T., Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Physiol. 1999, 277:F766-F772.
54. Meldrum K., Metcalfe P., Leslie J., Misseri R., Hile K., Meldrum D. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J. Surg. Res. 2006, 131:182-188.
55. Misseri R., Meldrum D., Dinarello C., Dagher P., Hile K., Rink R., Meldrum K. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am. J. Physiol. Renal Physiol. 2005, 288:F406-F411.
56. Morimoto Y., Gai Z., Tanishima H., Kawakatsu M., Itoh S., Hatamura I., Muragaki Y. TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp. Mol. Pathol. 2008, 85:207-213.
57. Higashi K., Kouba D.J., Song Y.J., Uitto J., Mauviel A. A proximal element within the human alpha 2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-alpha response element, mediates transcriptional repression by interferon-gamma. Matrix Biol. 1998, 16:447-456.
58. Okada H., Inoue T., Kanno Y., Kobayashi T., Watanabe Y., Ban S., Neilson E.G., Suzuki H. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int. 2003, 64:1722-1732.
59. Martinez-Salgado C., Fuentes-Calvo I., Garcia-Cenador B., Santos E., Lopez-Novoa J.M. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp. Cell Res. 2006, 312:2093-2106.
60. Robbins D.J., Cheng M., Zhen E., Vanderbilt C.A., Feig L.A., Cobb M.H. Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6924-6928.
61. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Clin. Exp. Immunol. 2006, 146:540-549.
62. Meighan-Mantha R.L., Hsu D.K., Guo Y., Brown S.A., Feng S.L., Peifley K.A., Alberts G.F., Copeland N.G., Gilbert D.J., Jenkins N.A., Richards C.M., Winkles J.A. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 1999, 274:33166-33176.
63. Ortiz A., Justo P., Sanz A., Lorz C., Egido J. Targeting apoptosis in acute tubular injury. Biochem. Pharmacol. 2003, 66:1589-1594.
64. Ricardo S., Ding G., Eufemio M., Diamond J. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am. J. Physiol. 1997, 272:F789-F798.
65. Truong L.D., Petrusevska G., Yang G., Gurpinar T., Shappell S., Lechago J., Rouse D., Suki W.N. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 1996, 50:200-207.
66. Munoz-Garcia B., Moreno J.A., Lopez-Franco O., Sanz A.B., Martin-Ventura J.L., Blanco J., Jakubowski A., Burkly L.C., Ortiz A., Egido J., Blanco-Colio L.M. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2061-2068.
67. Gonzalez-Cuadrado S., Bustos C., Ruiz-Ortega M., Ortiz A., Guijarro C., Plaza J.J., Egido J. Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin. Exp. Immunol. 1996, 106:518-522.
68. Sanz A.B., Sanchez-Nino M.D., Ramos A.M., Moreno J.A., Santamaria B., Ruiz-Ortega M., Egido J., Ortiz A. NF-kappaB in renal inflammation. J. Am. Soc. Nephrol. 2010, 21:1254-1262.
69. Kim K., Lee E., Cha S., Park J., Park J., Chang Y., Park K. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Exp. Mol. Pathol. 2009, 86:114-120.
70. Kitagawa K., Wada T., Furuichi K., Hashimoto H., Ishiwata Y., Asano M., Takeya M., Kuziel W.A., Matsushima K., Mukaida N., Yokoyama H. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 2004, 165:237-246.